Sun Pharmaceuticals reported 22.38B in EBIT for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Aspen Pharmacare APN:SJ 4.21B 494M
Bharat Petroleum BPCL:IN 20.23B 31.54B
Cipla CIPLA:IN 10.85B 5.74B
Dr.Reddys Laboratories DRRD:IN 6.34B 1.12B
Jiangsu Hengrui Me. 600276:CH 1.36B 311.08M
Reliance Infra RELI:IN 164.85B 1.07B
Sh Fosun Pharma 600196:CH 494.74M 264.83M
Sun Pharmaceuticals SUNP:IN 22.38B 7.32B
UPL UPLL:IN 13.12B 9.51B